Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    MANNOSE-BINDING PROTEIN DEFICIENCY
Show Display Options
RSS Create an RSS feed from your search for:
MANNOSE-BINDING PROTEIN DEFICIENCY
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Withdrawn Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia
Conditions: Fever, Sweats, and Hot Flashes;   Infection;   Leukemia;   Lymphoma;   Myelodysplastic Syndromes;   Neutropenia;   Unspecified Childhood Solid Tumor, Protocol Specific
Intervention: Biological: recombinant human mannose-binding lectin
2 Completed Study on Mannan Binding Lectin (MBL) Substitution in MBL-Deficient Children With Chemotherapy-Induced Neutropenia
Conditions: MBL-Deficient;   Neutropenia
Interventions: Drug: Mannan Binding Lectin (MBL);   Drug: Mannan Binding Lectin
3 Completed Association Between Deficiency of MBL (Mannose-Binding Lectin) and Polymorphisms in MBL2 Gene to Urinary Tract Infection
Condition: Recurrent Urinary Tract Infections
Intervention:
4 Withdrawn A Study of Safety, Tolerability, and Pk of rhMBL in Pediatric Hematology/Oncology Pts With Fever and Neutropenia
Conditions: Cancer;   Hematologic Diseases;   Fever;   Neutropenia
Intervention: Drug: Intravenous recombinant human mannose binding lectin

Indicates status has not been verified in more than two years